Evidence review · standard

ipamorelin

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ipamorelin`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ipamorelin

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ipamorelin/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ipamorelin/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ipamorelin/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ipamorelin/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

Regeneration vs degeneration — where this fits

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: Ipamorelin is studied as a selective GH secretagogue — repair and recovery signaling without the broad stress of exogenous GH.

What it is

2024 animal study showing ipamorelin (and anamorelin) reduces cisplatin-induced weight loss in ferrets during delayed phase when given intraperitoneally, with no effect on emesis itself. 2026 narrative review discussing ipamorelin among unapproved peptides, noting animal model benefits but scarce human safety data and regulatory concerns for sports medicine use.

How it works

Step logic:

  1. 2024 animal study showing ipamorelin (and anamorelin) reduces cisplatin-induced weight loss in ferrets during delayed phase when given intraperitoneally, with no effect on emesis itself.

Why it would work (logic chain)

  1. IF 2024 animal study showing ipamorelin (and anamorelin) reduces cisplatin-induced weight loss in ferrets during delayed phase when given intraperitoneally, with no effect on emesis itself. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  2. IF 2026 narrative review discussing ipamorelin among unapproved peptides, noting animal model benefits but scarce human safety data and regulatory concerns for sports medicine use. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).

How many people take it

There is no reliable global count of how many people take this compound. That number is not in this ledger.

What we can count from this ledger:

  • 0 anecdote source(s) (posts, threads, comments)
  • 0 anecdote-tier claim(s) derived from them

Logic: Without catalogued Reddit/X posts, this article cannot answer how many people take it — only what studies exist.

Evidence inventory

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 2
  • Claims tagged human evidence: 0
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 2

Logic: Studies exist in the ledger, but none are graded as strong human proof for the uses people discuss online. Animal and lab work is not the same as proof in people.

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.13 / 1.00 — very low

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism (source s1)

2024 animal study showing ipamorelin (and anamorelin) reduces cisplatin-induced weight loss in ferrets during delayed phase when given intraperitoneally, with no effect on emesis itself.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance (source s2)

2026 narrative review discussing ipamorelin among unapproved peptides, noting animal model benefits but scarce human safety data and regulatory concerns for sports medicine use.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Ipamorelin · peptide map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpBenzo WithdrawalBenzodiazepinesBrain FogCarpal Tunnel
Evidence · 2 sources · swipe →chain 50f46187c788 · verify chain · provenance
1 / 2
Evidence ledger 2 · tier-ranked · API
preclinical
2024 animal study showing ipamorelin (and anamorelin) reduces cisplatin-induced weight loss in ferrets during delayed phase when given intraperitoneally, with no effect on emesis itself.
sources: s1
preclinical
2026 narrative review discussing ipamorelin among unapproved peptides, noting animal model benefits but scarce human safety data and regulatory concerns for sports medicine use.
sources: s2
Model swipes · 2 from 1 model · swipe →verify
1 / 2
grok-4.3writer
draft2026-06-29 17:03
ipamorelin
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ipamorelin
it output
2 source(s) added
dd5782286f36c317
grok-4.3source_hunt
sources2026-06-29 17:03
2 source(s) added · 2 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ipamorelin
it output
2 source(s) added
f183fd3e646c0bfe

Related research

Ipamorelin · peptide map

Open evidence map →
Benzo Withdrawalipamorelin-benzo-withdrawalBenzodiazepinesipamorelin-benzodiazepinesBrain Fogipamorelin-brain-fogCarpal Tunnelipamorelin-carpal-tunnelChemoipamorelin-chemoChemo Neuropathyipamorelin-chemo-neuropathyCognitionipamorelin-cognitionCorticosteroidsipamorelin-corticosteroidsDiabetic Neuropathyipamorelin-diabetic-neuropathyFrozen Shoulderipamorelin-frozen-shoulder
Ask this article · 4 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "2024 animal study showing ipamorelin (and anamorelin) reduces cisplatin-induced weight loss in ferrets during delayed phase when given intra…"?
ask ipamorelin claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "2026 narrative review discussing ipamorelin among unapproved peptides, noting animal model benefits but scarce human safety data and regulat…"?
ask ipamorelin claim c2 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about ipamorelin — and what would you need me to tell you first?
ask ipamorelin condition gaps · paste includes §SELF
What good and bad outcomes are documented for ipamorelin (studies vs anecdotes)?
ask ipamorelin good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →